XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ (122,588)   $ 2 $ 4,275   $ (126,865)
Temporary equity, Beginning balance, Shares at Dec. 31, 2018   18,670,328        
Temporary equity, Beginning balance at Dec. 31, 2018   $ 152,806        
Beginning balance, Shares at Dec. 31, 2018     1,824,852      
Exercise of common stock warrants for cash 110     110    
Exercise of common stock warrants for cash, Shares     50,331      
Issuance of common stock upon net exercise of warrants 133     133    
Issuance of common stock upon net exercise of warrants, Shares     101,744      
Conversion of preferred stock to common stock upon initial public offering 152,806   $ 18 152,788    
Temporary equity, Conversion of preferred stock to common stock upon initial public offering, Shares   (18,670,328)        
Temporary equity, Conversion of preferred stock to common stock upon initial public offering   $ (152,806)        
Conversion of preferred stock to common stock upon initial public offering, Shares     18,670,328      
Conversion of Series A-1 warrants to common stock warrants upon initial public offering 789     789    
Issuance of common stock in connection with initial/public offering 100,139   $ 7 100,132    
Issuance of common stock in connection with initial/public offering, Shares     6,555,000      
Issuance of common stock in connection with private placement 10,000   $ 1 9,999    
Issuance of common stock in connection with private placement, Shares     588,235      
Exercise of stock options 169     169    
Exercise of stock options, Shares     80,515      
Vesting of early exercised options 18     18    
Offering cost related to the initial/public offering (11,300)          
Stock-based compensation 412     412    
Settlement of fractional shares resulting from reverse stock split (3)     (3)    
Settlement of fractional shares resulting from reverse stock split, Shares     (114)      
Net loss (12,799)         (12,799)
Ending balance at Mar. 31, 2019 129,186   $ 28 268,822   (139,664)
Ending balance, shares at Mar. 31, 2019     27,870,891      
Beginning balance at Dec. 31, 2018 (122,588)   $ 2 4,275   (126,865)
Temporary equity, Beginning balance, Shares at Dec. 31, 2018   18,670,328        
Temporary equity, Beginning balance at Dec. 31, 2018   $ 152,806        
Beginning balance, Shares at Dec. 31, 2018     1,824,852      
Net loss (36,364)          
Ending balance at Sep. 30, 2019 108,250   $ 28 271,394 $ 57 (163,229)
Ending balance, shares at Sep. 30, 2019     28,255,893      
Beginning balance at Mar. 31, 2019 129,186   $ 28 268,822   (139,664)
Beginning balance, Shares at Mar. 31, 2019     27,870,891      
Issuance of common stock upon net exercise of warrants, Shares     79,208      
Exercise of stock options 148     148    
Exercise of stock options, Shares     73,608      
Vesting of early exercised options 9     9    
Offering cost related to the initial/public offering (215)     (215)    
Unrealized gain (loss) on available-for- sale securities 75       75  
Stock-based compensation 818     818    
Net loss (10,608)         (10,608)
Ending balance at Jun. 30, 2019 119,413   $ 28 269,582 75 (150,272)
Ending balance, shares at Jun. 30, 2019     28,023,707      
Exercise of stock options 706     706    
Exercise of stock options, Shares     232,186      
Unrealized gain (loss) on available-for- sale securities (18)       (18)  
Stock-based compensation 1,106     1,106    
Net loss (12,957)         (12,957)
Ending balance at Sep. 30, 2019 108,250   $ 28 271,394 57 (163,229)
Ending balance, shares at Sep. 30, 2019     28,255,893      
Beginning balance at Dec. 31, 2019 192,653   $ 31 370,561 35 (177,974)
Beginning balance, Shares at Dec. 31, 2019     31,446,787      
Exercise of stock options 1,113   $ 1 1,112    
Exercise of stock options, Shares     356,128      
Issuance of common stock under employee stock purchase plan 842     842    
Issuance of common stock under employee stock purchase plan, Share     24,691      
Unrealized gain (loss) on available-for- sale securities 68       68  
Stock-based compensation 1,871     1,871    
Net loss (18,775)         (18,775)
Ending balance at Mar. 31, 2020 177,772   $ 32 374,386 103 (196,749)
Ending balance, shares at Mar. 31, 2020     31,827,606      
Beginning balance at Dec. 31, 2019 $ 192,653   $ 31 370,561 35 (177,974)
Beginning balance, Shares at Dec. 31, 2019     31,446,787      
Exercise of stock options, Shares 747,829          
Net gain reclassified from accumulated other comprehensive income $ (21)          
Net loss (49,825)          
Ending balance at Sep. 30, 2020 237,047   $ 34 464,812   (227,799)
Ending balance, shares at Sep. 30, 2020     34,236,165      
Beginning balance at Mar. 31, 2020 177,772   $ 32 374,386 103 (196,749)
Beginning balance, Shares at Mar. 31, 2020     31,827,606      
Issuance of common stock in connection with initial/public offering 83,382   $ 2 83,380    
Issuance of common stock in connection with initial/public offering, Shares     1,955,000      
Exercise of stock options 480     480    
Exercise of stock options, Shares     137,178      
Offering cost related to the initial/public offering (6,100)          
Issuance of common stock in connection with vesting of restricted stock units, Shares     41,229      
Restricted stock units withheld in net settlement for tax (616)     (616)    
Restricted stock units withheld in net settlement for tax, Shares     (15,456)      
Unrealized gain (loss) on available-for- sale securities (82)       (82)  
Stock-based compensation 2,605     2,605    
Net loss (18,118)         (18,118)
Ending balance at Jun. 30, 2020 245,423   $ 34 460,235 21 (214,867)
Ending balance, shares at Jun. 30, 2020     33,945,557      
Exercise of stock options 993     993    
Exercise of stock options, Shares     254,523      
Issuance of common stock under employee stock purchase plan 953     953    
Issuance of common stock under employee stock purchase plan, Share     27,921      
Offering cost related to the initial/public offering (14)     (14)    
Issuance of common stock in connection with vesting of restricted stock units, Shares     12,775      
Restricted stock units withheld in net settlement for tax (246)     (246)    
Restricted stock units withheld in net settlement for tax, Shares     (4,611)      
Stock-based compensation 2,891     2,891    
Net gain reclassified from accumulated other comprehensive income (21)       $ (21)  
Net loss (12,932)         (12,932)
Ending balance at Sep. 30, 2020 $ 237,047   $ 34 $ 464,812   $ (227,799)
Ending balance, shares at Sep. 30, 2020     34,236,165